Preventive Care for a 60-Year-Old Transgender Woman
A 60-year-old transgender woman should receive breast cancer screening with mammography if she has received 5 or more years of feminizing hormone therapy, starting at age 50 (which she has already reached), with screening performed either annually or biennially depending on the guideline followed. 1
Breast Cancer Screening
The most critical preventive care consideration for this patient is breast cancer screening, which varies based on hormone therapy duration:
If ≥5 Years of Feminizing Hormone Therapy:
- Start mammography screening at age 50 (already indicated for this 60-year-old patient)
- Frequency options:
The American College of Radiology provides additional nuance: For patients aged 40+ with ≥5 years of past or current hormone treatment, screening mammography or digital breast tomosynthesis may be appropriate 1. For higher-risk patients (personal/family history of breast cancer, chest irradiation, genetic predispositions), screening is "usually appropriate" 1.
If <5 Years of Hormone Therapy:
- No routine screening necessary 1
Important context: Breast cancer risk in transgender women on hormone therapy (4.1 per 100,000 person-years) is significantly higher than cisgender men (1.28 per 100,000) but substantially lower than cisgender women (155 per 100,000) 1.
Prostate Cancer Screening
Screen for prostate cancer following guidelines for cisgender men, despite feminizing hormone therapy:
- Annual digital rectal examination after age 50 2
- PSA testing consistent with U.S. Preventive Services Task Force Guidelines 2
Critical pitfall: Transgender women may avoid prostate screening due to discomfort or dysphoria, and gynecologists are not trained to perform these exams 2. Ensure this screening is not overlooked despite gender-affirming care.
Rationale: While androgen deprivation reduces prostate cancer risk, cases have been reported in transgender women, particularly those who transitioned after age 50 2. The prostate does not regress completely with estrogen therapy.
Cardiovascular Risk Assessment
Perform comprehensive cardiovascular risk stratification:
- Screen for hypertension, hypercholesterolemia, and diabetes - all more prevalent in transgender populations 3, 4
- Monitor glucose and lipid metabolism regularly 2
- Assess for traditional cardiovascular risk factors including smoking (higher prevalence in transgender individuals) 4
Hormone therapy considerations: Estrogen therapy in transgender women may affect cardiovascular risk, though data are limited. Endothelial function may be enhanced compared to cisgender men 3.
Bone Health
Assess bone mineral density if risk factors are present:
- Obtain DXA scan if: history of gonadectomy, discontinuation of hormone therapy, or other osteoporosis risk factors 2
- Monitor regularly if hormone therapy is interrupted or discontinued after gonadectomy 2
Note: The 2025 USPSTF guidelines acknowledge insufficient evidence for bone density screening in transgender persons, calling for more research 5. In the absence of definitive data, use clinical judgment based on individual risk factors.
Mental Health and Substance Use
Screen for:
- Depression and anxiety - significantly elevated in transgender populations due to minority stress 3
- Alcohol and substance use disorders - higher prevalence than general population 3
- Sleep disturbances - associated with gender identity concerns and minority stress 3
- History of victimization or trauma - common and impacts health outcomes 1
Standard Age-Appropriate Preventive Care
Apply standard 60-year-old preventive guidelines:
- Colorectal cancer screening
- Vaccinations (influenza, pneumococcal, shingles, COVID-19)
- Lipid screening
- Diabetes screening
- Hypertension monitoring
Hormone Therapy Monitoring
If on gender-affirming hormone therapy:
- Monitor hormone levels (estradiol, testosterone) every 3 months in first year, then 1-2 times yearly 2
- Monitor prolactin levels in transgender women on estrogen 2
- Clinical assessment for feminization effects and patient satisfaction 2
Creating an Inclusive Environment
To optimize care delivery:
- Use correct pronouns and preferred name
- Ensure intake forms have non-binary gender options
- Train staff in transgender-specific considerations
- Display inclusive materials (e.g., transgender flag) 1
Critical consideration: Transgender individuals face significant barriers to preventive care due to discrimination, stigma, and prior negative healthcare experiences 1, 6. Building trust through affirming care is essential for effective preventive health delivery.